Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02445183 · ClinicalTrials.gov registry record
COPDGene/Lung Cancer Center Database
A clinical trial, sponsored by National Jewish Health.
- Completed
- Registry status
- 250
- Enrollment target
NCT02445183 is a clinical trial that has completed, run by National Jewish Health. The registered enrollment target is 250 participants.
The verdict
NCT02445183 has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 250 participants
- Enrollment target
Study Summary
The COPDGene® / Lung Cancer Database Study is a nested case-control study. This study is an ancillary study to COPDGene® Phase 1 and Phase 2. Lung cancer cases, which have been reported by COPDGene® subjects since the time of COPDGene® study enrollment, will be retrospectively verified with additional medical data collection pertaining to lung cancer. Additional 'control' subjects will also be identified and verified as a 'no lung cancer controls'. Data previously collected through the COPDGene® Study, including QCT results and clinical results (medication use, rate of acute exacerbations of COPD, etc) will be used as variables for analysis.
Interventions
- OTHER None, N/A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2013-12 |
| Est. Completion | 2020-09-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02445183
The ClinicalTrials.gov registry entry for NCT02445183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which None, N/A is the first listed.
NCT02445183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02445183 about?
NCT02445183 is a clinical study titled "COPDGene/Lung Cancer Center Database". The COPDGene® / Lung Cancer Database Study is a nested case-control study. This study is an ancillary study to COPDGene® Phase 1 and Phase 2. Lung cancer cases, which have been reported by COPDGene® subjects since the time of COPDGene® study enrollment, will be retrospectively verified with addition...
What is the current status of trial NCT02445183?
This trial is currently completed. The enrollment target is 250 participants. The study started on 2013-12. Estimated completion is 2020-09-22.
What interventions are being tested in trial NCT02445183?
The interventions under investigation include: None, N/A (OTHER).
Who is sponsoring clinical trial NCT02445183?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.